Christine Jenkins's Publications

About Christine Jenkins's Publications

Program Head, Respiratory
  • Professor of Respiratory Medicine, Faculty of Medicine, UNSW Sydney
  • Clinical Professor, Concord Clinical School, University of Sydney
  • AM,
  • MD,
  • FRACP,
  • FThor ,
  • Soc ,
  • FAAHMS

  • Treatable traits can be identified in a severe asthma registry and predict future exacerbations

    Respirology Date published:

  • Increased sputum FKBP51 gene expression following Azithromycin add-on therapy in asthma

    Clinical Problems Date published:

  • Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors

    Monitoring airway disease Date published:

  • Associations of sedentary behaviour and physical activity phenotypes with health outcomes in COPD: a cohort study

    Physiotherapists Date published:

  • Working while unwell: Workplace impairment in people with severe asthma

    Clinical & Experimental Allergy Date published:

  • Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial

    The Lancet Respiratory Medicine Date published:

  • Low leisure-based sitting time and being physically active were associated with reduced odds of death and diabetes in people with chronic obstructive pulmonary disease: a cohort study

    Journal of Physiotherapy Date published:

  • Real-world study of acute exacerbations of COPD reveals real gaps in care

    Respirology Date published:

  • Starting beta-blockers during exacerbations of chronic obstructive pulmonary disease

    Internal Medicine Journal Date published:

  • DIAGNOSIS OF DYSPNEA: A LITERATURE REVIEW

    Date published:

  • Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology

    Journal of Allergy and Clinical Immunology Date published:

  • Effects of ground-based walking training on daily physical activity in people with COPD: A randomised controlled trial

    Respiratory Medicine Date published:

  • Sputum IL-1β is reduced with Azithromycin add-on therapy in patients with poorly controlled asthma

    Allergy and immunology Date published:

  • The paradoxes of asthma management: time for a new approach?

    European Respiratory Journal Date published:

  • Eliminating asthma deaths: have we stalled?

    The Lancet Date published:

  • Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial

    The Lancet Date published: